Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lydia Scarfò

Showing results (21-30 of 143) with videos related to

Pageof 15
Sort By:
Open Biology|May 14, 2020
EZN-2208 treatment suppresses chronic lymphocytic leukaemia by interfering with environmental protection and increases response to fludarabineRoberta Valsecchi, Nadia Coltella, Daniela Magliulo, et al.
Blood|January 28, 2017
Efficacy and safety of dinaciclib vs ofatumumab in patients with relapsed/refractory chronic lymphocytic leukemiaPaolo Ghia, Lydia Scarfò, Susan Perez, et al.
European Journal of Immunology|August 10, 2023
Dimethyl itaconate selectively targets inflammatory and metabolic pathways in chronic lymphocytic leukemiaIlenia Sana, Maria Elena Mantione, Miriam Meloni, et al.
Journal of Clinical Medicine|April 23, 2022
Old and New Drugs for Chronic Lymphocytic Leukemia: Lights and Shadows of Real-World EvidenceMonia Marchetti, Candida Vitale, Gian Matteo Rigolin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 11, 2012
In vitro sensitivity of CLL cells to fludarabine may be modulated by the stimulation of Toll-like receptorsEleonora Fonte, Benedetta Apollonio, Lydia Scarfò, et al.
Leukemia Research|December 14, 2020
Response assessment to venetoclax in relapsed/refractory chronic lymphocytic leukemia by ultrasonographyEdoardo Benedetti, Claudia Baratè, Benedetto Bruno, et al.
Cytometry. Part B, Clinical Cytometry|September 15, 2010
Monoclonal B cell lymphocytosis in hepatitis C virus infected individualsClaudia Fazi, Antonis Dagklis, Francesca Cottini, et al.
Journal of Cellular and Molecular Medicine|February 7, 2023
PYK2 is overexpressed in chronic lymphocytic leukaemia: A potential new therapeutic targetFrancesca Vittoria Sbrana, Benedetta Fiordi, Jessica Bordini, et al.
Frontiers in Cell and Developmental Biology|July 19, 2021
3D-STED Super-Resolution Microscopy Reveals Distinct Nanoscale Organization of the Hematopoietic Cell-Specific Lyn Substrate-1 (HS1) in Normal and Leukemic B CellsMarta Sampietro, Moreno Zamai, Alfonsa Díaz Torres, et al.
Scientific Reports|March 13, 2019
Computational analysis of the evolutionarily conserved Missing In Metastasis/Metastasis Suppressor 1 gene predicts novel interactions, regulatory regions and transcriptional controlPetar Petrov, Alexey V Sarapulov, Lel Eöry, et al.
Pageof 15

Showing results (21-30 of 143) with videos related to

Sort By:
Pageof 15
Open Biology|May 14, 2020
EZN-2208 treatment suppresses chronic lymphocytic leukaemia by interfering with environmental protection and increases response to fludarabineRoberta Valsecchi, Nadia Coltella, Daniela Magliulo, et al.
Blood|January 28, 2017
Efficacy and safety of dinaciclib vs ofatumumab in patients with relapsed/refractory chronic lymphocytic leukemiaPaolo Ghia, Lydia Scarfò, Susan Perez, et al.
European Journal of Immunology|August 10, 2023
Dimethyl itaconate selectively targets inflammatory and metabolic pathways in chronic lymphocytic leukemiaIlenia Sana, Maria Elena Mantione, Miriam Meloni, et al.
Journal of Clinical Medicine|April 23, 2022
Old and New Drugs for Chronic Lymphocytic Leukemia: Lights and Shadows of Real-World EvidenceMonia Marchetti, Candida Vitale, Gian Matteo Rigolin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 11, 2012
In vitro sensitivity of CLL cells to fludarabine may be modulated by the stimulation of Toll-like receptorsEleonora Fonte, Benedetta Apollonio, Lydia Scarfò, et al.
Leukemia Research|December 14, 2020
Response assessment to venetoclax in relapsed/refractory chronic lymphocytic leukemia by ultrasonographyEdoardo Benedetti, Claudia Baratè, Benedetto Bruno, et al.
Cytometry. Part B, Clinical Cytometry|September 15, 2010
Monoclonal B cell lymphocytosis in hepatitis C virus infected individualsClaudia Fazi, Antonis Dagklis, Francesca Cottini, et al.
Journal of Cellular and Molecular Medicine|February 7, 2023
PYK2 is overexpressed in chronic lymphocytic leukaemia: A potential new therapeutic targetFrancesca Vittoria Sbrana, Benedetta Fiordi, Jessica Bordini, et al.
Frontiers in Cell and Developmental Biology|July 19, 2021
3D-STED Super-Resolution Microscopy Reveals Distinct Nanoscale Organization of the Hematopoietic Cell-Specific Lyn Substrate-1 (HS1) in Normal and Leukemic B CellsMarta Sampietro, Moreno Zamai, Alfonsa Díaz Torres, et al.
Scientific Reports|March 13, 2019
Computational analysis of the evolutionarily conserved Missing In Metastasis/Metastasis Suppressor 1 gene predicts novel interactions, regulatory regions and transcriptional controlPetar Petrov, Alexey V Sarapulov, Lel Eöry, et al.
Pageof 15